Fridriksdottir Hafrun
Executive VP, Global R&D at TEVA
- Sold, on record
- $3.7M
- Dollars the filings state
- Form 4 sales
- 22
- Latest May 17, 2022
- Form 144 notices
- 0
- Proposed sales
- Companies
- 1
- Filed as an executive or holder
Companies
- TEVATEVA PHARMACEUTICAL INDUSTRIES LTDExecutive VP, Global R&D
Sales by reason
Form 4 sales per month, last 12 months.
Timeline
- 1 Form 4 sale TEVAUnusualMar 2, 2021 2021
Sold 50,000 shares at $10.82 ($541k)
Fridriksdottir Hafrun, Executive VP, Global R&D
Sold 43.8% of holdings ($1.2M position)64,064 shares left14.8x usual sizeFiling
- 2 Form 4 sale TEVAPlan not statedMar 4, 2021 +2 days
Sold 9,515 shares at $10.57 ($101k)
Fridriksdottir Hafrun, Executive VP, Global R&D
Sold 11.5% of holdings ($877k position)73,454 shares left1.9x usual sizeFiling
- 3 Form 4 sale TEVAPlan not statedMay 11, 2021 +68 days
Sold 19,066 shares at $10.22 ($195k)
Fridriksdottir Hafrun, Executive VP, Global R&D
Sold 17.1% of holdings ($1.1M position)92,272 shares left2.5x usual sizeFiling
- 4 Form 4 sale TEVAUnusualAug 10, 2021 +91 days
Sold 50,860 shares at $9.95 ($506k)
Fridriksdottir Hafrun, Executive VP, Global R&D
Sold 55.1% of holdings ($918k position)41,412 shares left5.3x usual sizeFiling
- 5 Form 4 sale TEVAPlan not statedFeb 9, 2022 +183 days
Sold 6,116 shares at $9.06 ($55k)
Fridriksdottir Hafrun, Executive VP, Global R&D
Sold 10.6% of holdings ($521k position)51,417 shares left0.5x usual sizeFiling
- 6 Form 4 sale TEVAPlan not statedFeb 28, 2022 +19 days
Sold 7,590 shares at $8.14 ($62k)
Fridriksdottir Hafrun, Executive VP, Global R&D
Sold 10.4% of holdings ($595k position)65,509 shares left0.7x usual sizeFiling
- 7 Form 4 sale TEVAUnusualMar 7, 2022 +7 days
Sold 33,579 shares at $7.45 ($250k)
Fridriksdottir Hafrun, Executive VP, Global R&D
Sold 21% of holdings ($1.2M position)126,087 shares left3.3x usual sizeFiling
- 8 Form 4 sale TEVAUnusualMay 17, 2022 +71 days
Sold 130,000 shares at $8.22 ($1.1M)
Fridriksdottir Hafrun, Executive VP, Global R&D
Sold 98.9% of holdings ($1.1M position)1,387 shares left8.7x usual sizeFiling
Every transaction
Loading transactions…
Sales and notices (22)
| Source | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| May 17, 2022 | May 19, 2022 | TEVA | Executive VP, Global R&D | Form 4 sale | 130,000 | $1.1M | 98.9% | Unusual | SEC |
| Mar 7, 2022 | Mar 8, 2022 | TEVA | Executive VP, Global R&D | Form 4 sale | 33,579 | $250k | 21.0% | Unusual | SEC |
| Feb 28, 2022 | Mar 2, 2022 | TEVA | Executive VP, Global R&D | Form 4 sale | 7,590 | $62k | 10.4% | Plan not stated | SEC |
| Feb 9, 2022 | Feb 10, 2022 | TEVA | Executive VP, Global R&D | Form 4 sale | 6,116 | $55k | 10.6% | Plan not stated | SEC |
| Aug 10, 2021 | Aug 12, 2021 | TEVA | Executive VP, Global R&D | Form 4 sale | 50,860 | $506k | 55.1% | Unusual | SEC |
| May 11, 2021 | May 13, 2021 | TEVA | Executive VP, Global R&D | Form 4 sale | 19,066 | $195k | 17.1% | Plan not stated | SEC |
| Mar 4, 2021 | Mar 8, 2021 | TEVA | Executive VP, Global R&D | Form 4 sale | 9,515 | $101k | 11.5% | Plan not stated | SEC |
| Mar 2, 2021 | Mar 4, 2021 | TEVA | Executive VP, Global R&D | Form 4 sale | 50,000 | $541k | 43.8% | Unusual | SEC |
| Mar 1, 2021 | Mar 2, 2021 | TEVA | Executive VP, Global R&D | Form 4 sale | 10,912 | $118k | 8.7% | Unusual | SEC |
| Feb 16, 2021 | Feb 17, 2021 | TEVA | Executive VP, Global R&D | Form 4 sale | 2,098 | $23k | 2.0% | Plan not stated | SEC |
| Feb 9, 2021 | Feb 11, 2021 | TEVA | Executive VP, Global R&D | Form 4 sale | 29,496 | $374k | 22.8% | Unusual | SEC |
| Mar 17, 2020 | Mar 19, 2020 | TEVA | Executive VP, Global R&D | Form 4 sale | 514 | $4k | 1.1% | Plan not stated | SEC |
| Feb 14, 2020 | Feb 18, 2020 | TEVA | Executive VP, Global R&D | Form 4 sale | 11,472 | $139k | 20.3% | Unusual | SEC |
| Feb 10, 2020 | Feb 11, 2020 | TEVA | Executive VP, Global R&D | Form 4 sale | 5,544 | $68k | 14.3% | Unusual | SEC |
| Dec 31, 2019 | Jan 2, 2020 | TEVA | Executive VP, Global R&D | Form 4 sale | 2,459 | $24k | 9.8% | Plan not stated | SEC |
| Dec 2, 2019 | Dec 3, 2019 | TEVA | Executive VP, Global R&D | Form 4 sale | 4,310 | $45k | 17.3% | Unusual | SEC |
| Mar 18, 2019 | Mar 19, 2019 | TEVA | Executive VP, Global R&D | Form 4 sale | 356 | $6k | 2.1% | Plan not stated | SEC |
| Mar 4, 2019 | Mar 5, 2019 | TEVA | Executive VP, Global R&D | Form 4 sale | 409 | $7k | 2.5% | Plan not stated | SEC |
| Feb 14, 2019 | Feb 19, 2019 | TEVA | Executive VP, Global R&D | Form 4 sale | 1,841 | $33k | 10.7% | Plan not stated | SEC |
| Jan 2, 2019 | Jan 3, 2019 | TEVA | Executive VP, Global R&D | Form 4 sale | 1,643 | $26k | 12.2% | Plan not stated | SEC |
| Nov 30, 2018 | Dec 4, 2018 | TEVA | Executive VP, Global R&D | Form 4 sale | 933 | $20k | 9.6% | Plan not stated | SEC |
| Mar 19, 2018 | Mar 20, 2018 | TEVA | Executive VP, Global R&D | Form 4 sale | 348 | $6k | 4.7% | Plan not stated | SEC |